Pancreatic Cancer Research

ResearcherSeoul National UniversityActive in the last 2 years

Ijin Joo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1341-4072; OpenAlex author ID A5024539141. Sources: OpenAlex.

Their work

Papers
16 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
41
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: 2 papers · 2016: none · 2017: 2 papers · 2018: 2 papers · 2019: 3 papers · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers

Papers 16

  1. Prognostic value of initial and longitudinal changes in body composition in metastatic pancreatic cancer. Co-author DOI 10.1002/jcsm.13437↗
  2. Important Radiologic and Clinical Factors for Predicting Overall Survival in Pancreatic Adenocarcinoma Patients Who Underwent FOLFIRINOX. Last author DOI 10.1097/mpa.0000000000002330↗
  3. Post-neoadjuvant treatment pancreatic cancer resectability and outcome prediction using CT, 18F-FDG PET/MRI and CA 19-9. Co-author DOI 10.1186/s40644-023-00565-8↗
  4. How to approach pancreatic cancer after neoadjuvant treatment: assessment of resectability using multidetector CT and tumor markers. Co-author DOI 10.1007/s00330-021-08108-0↗
  5. Predictors of conversion surgery in patients with pancreatic cancer who underwent neoadjuvant or palliative FOLFIRINOX treatment using baseline and follow-up C… Co-author DOI 10.1007/s00261-021-03127-3↗
  6. Important CT and histopathological findings for recurrence and overall survival in patients with pancreatic ductal adenocarcinoma who underwent surgery after n… Co-author DOI 10.1007/s00330-020-07489-y↗
  7. CT prediction of resectability and prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant treatment using image findings and texture ana… Co-author DOI 10.1007/s00330-018-5574-0↗
  8. MDCT findings predicting post-operative residual tumor and survival in patients with pancreatic cancer. Co-author DOI 10.1007/s00330-019-06140-9↗
  9. Preoperative CT Classification of the Resectability of Pancreatic Cancer: Interobserver Agreement. Co-author DOI 10.1148/radiol.2019190422↗
  10. Magnetic resonance with diffusion-weighted imaging improves assessment of focal liver lesions in patients with potentially resectable pancreatic cancer on CT. Co-author DOI 10.1007/s00330-017-5258-1↗
  11. Preoperative MDCT Assessment of Resectability in Borderline Resectable Pancreatic Cancer: Effect of Neoadjuvant Chemoradiation Therapy. Co-author DOI 10.2214/ajr.17.18310↗
  12. Preoperative Assessment of Pancreatic Cancer with FDG PET/MR Imaging versus FDG PET/CT Plus Contrast-enhanced Multidetector CT: A Prospective Preliminary Study. Co-author DOI 10.1148/radiol.2016152798↗
  13. Survival outcome and prognostic factors of neoadjuvant treatment followed by resection for borderline resectable pancreatic cancer. Co-author DOI 10.4174/astr.2017.93.4.186↗
  14. Differential diagnosis of pancreatic cancer from other solid tumours arising from the periampullary area on MDCT. Co-author DOI 10.1007/s00330-015-3721-4↗
  15. Prognostic value of splenic artery invasion in patients undergoing adjuvant chemoradiotherapy after distal pancreatectomy for pancreatic adenocarcinoma. Co-author DOI 10.4143/crt.2014.025↗
  16. Magnetic resonance imaging findings of the mass-forming type of autoimmune pancreatitis: comparison with pancreatic adenocarcinoma. Co-author DOI 10.1002/jmri.23609↗

Closest collaborators

The 25 strongest of 41 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jung Hoon Kim · 7 shared papers, 2012–2024 · strength 0.99
  2. Jeong Min Lee · 7 shared papers, 2012–2024 · strength 0.86
  3. Joon Koo Han · 7 shared papers, 2012–2021 · strength 0.76
  4. Jin‐Young Jang · 7 shared papers, 2015–2023 · strength 0.69
  5. Sae‐Jin Park · 3 shared papers, 2021–2024 · strength 0.67
  6. Jeong Hee Yoon · 3 shared papers, 2022–2024 · strength 0.59
  7. Sun Kyung Jeon · 3 shared papers, 2018–2024 · strength 0.48
  8. Sang Hyub Lee · 2 shared papers, 2023–2024 · strength 0.43
  9. Seo‐Youn Choi · 2 shared papers, 2019–2024 · strength 0.42
  10. Eun Sun Lee · 4 shared papers, 2017–2022 · strength 0.39
  11. Su Joa Ahn · 4 shared papers, 2018–2019 · strength 0.36
  12. Mi Hye Yu · 2 shared papers, 2022–2023 · strength 0.35
  13. Dong Ho Lee · 4 shared papers, 2017–2019 · strength 0.32
  14. Sun‐Whe Kim · 4 shared papers, 2015–2018 · strength 0.26
  15. Woo Hyun Paik · 1 shared paper, 2024 · strength 0.24
  16. Min Woo Lee · 1 shared paper, 2024 · strength 0.24
  17. Jeongin Yoo · 1 shared paper, 2023 · strength 0.19
  18. Hyun Kyung Yang · 2 shared papers, 2018–2019 · strength 0.17
  19. Sang Hyup Lee · 1 shared paper, 2022 · strength 0.16
  20. Ji Kon Ryu · 2 shared papers, 2017–2018 · strength 0.14
  21. Kyoung-Bun Lee · 2 shared papers, 2017–2018 · strength 0.14
  22. Jae Seok Bae · 1 shared paper, 2019 · strength 0.12
  23. Kyubo Kim · 2 shared papers, 2015–2018 · strength 0.12
  24. Do‐Youn Oh · 2 shared papers, 2015–2018 · strength 0.12
  25. Bo Ram Kim · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.